Alok Khorana: Six Years of Growth and Transformation at National Blood Clot Alliance
Alok Khorana, Vice Chair of the Taussig Cancer Institute at Cleveland Clinic, shared a post on LinkedIn:
“It’s been a dynamic six years of growth and transformation as I reach the end of my second and final term as Chair of the Medical and Scientific Advisory Board of National Blood Clot Alliance. From creating the Council for Emerging Researchers in Thrombosis (CERT) to effective public policy advances at state and federal levels such as the passage of the Emily Adkins Act in Florida, I couldn’t have asked for a better partner than Leslie Lake. She is an inspirational leader who has changed the boundaries of what’s possible in this patient-led organization.
I’m excited to hand off leadership to incoming Chair Jeffrey Zwicker who I’m absolutely confident will lead the Board to newer and greater heights.
Finally, I’m absolutely delighted to remain involved with MASAB and NBCA as Chair Emeritus. Much has been done to alleviate the public health and individual burden of thromboembolism but much remains to be done.”
Stay updated with Hemostasis Today.
-
May 24, 2026, 00:54Andreas Ejlegard: The Promise of Smarter Antithrombotic Therapy with Cereno Scientific
-
May 24, 2026, 00:43Patient Advocacy and Clinical Excellence United at the European Certificate in Clinical Haemostasis – EHC
-
May 24, 2026, 00:41Mass General Brigham Research: Advancing the Future of Gene and Cell Therapy
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders